Sec Form 13G Filing - Ionic Ventures LLC filing for Algorhythm Holdings, Inc. (RIME) - 2025-02-04

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  The number of shares of the issuer's common stock, par value $0.01 per share (the ''Common Stock''), outstanding and beneficially owned by the reporting person and the associated CUSIP number for the Common Stock disclosed in this Amendment No. 1 to Statement on Schedule 13G (this ''Amendment No. 1'') do not give effect to the 1-for-200 reverse split of the outstanding shares of Common Stock effected by the issuer on January 14, 2025 (the ''Reverse Stock Split''), which has not been reflected on the Nasdaq Capital Market (''Nasdaq'') as of the date of this Amendment No. 1. As more fully described in Item 4 of this Amendment No. 1, such shares and percentage are based on 94,164,916 shares of Common Stock, as disclosed in the issuer's prospectus supplement, dated December 17, 2024, to the registration statement on Form S-3, as amended (File No. 333-269183), declared effective by the U.S. Securities and Exchange Commission on January 20, 2023 (the ''Prospectus Supplement''), and do not give full effect to the Series A common stock purchase warrants of the issuer (the ''Series A Warrants'') directly owned by the reporting person or the Series B common stock purchase warrants of the issuer (the ''Series B Warrants'', and together with the Series A Warrants, the ''Warrants'') directly owned by the reporting person, each subject to a 9.99% beneficial ownership limitation provision (the ''Blocker'').


SCHEDULE 13G



Comment for Type of Reporting Person:  The number of shares of Common Stock outstanding and beneficially owned by the reporting person and the associated CUSIP number for the Common Stock disclosed in this Amendment No. 1 do not give effect to the Reverse Stock Split, which has not been reflected on Nasdaq as of the date of this Amendment No. 1. As more fully described in Item 4 of this Amendment No. 1, such shares and percentage are based on 94,164,916 shares of Common Stock, as disclosed in the Prospectus Supplement, and do not give full effect to the Warrants indirectly owned by the reporting person, each subject to a 9.99% Blocker.


SCHEDULE 13G



Comment for Type of Reporting Person:  The number of shares of Common Stock outstanding and beneficially owned by the reporting person and the associated CUSIP number for the Common Stock disclosed in this Amendment No. 1 do not give effect to the Reverse Stock Split, which has not been reflected on Nasdaq as of the date of this Amendment No. 1. As more fully described in Item 4 of this Amendment No. 1, such shares and percentage are based on 94,164,916 shares of Common Stock, as disclosed in the Prospectus Supplement, and do not give full effect to the Warrants indirectly owned by the reporting person, each subject to a 9.99% Blocker.


SCHEDULE 13G



Comment for Type of Reporting Person:  The number of shares of Common Stock outstanding and beneficially owned by the reporting person and the associated CUSIP number for the Common Stock disclosed in this Amendment No. 1 do not give effect to the Reverse Stock Split, which has not been reflected on Nasdaq as of the date of this Amendment No. 1. As more fully described in Item 4 of this Amendment No. 1, such shares and percentage are based on 94,164,916 shares of Common Stock, as disclosed in the Prospectus Supplement, and do not give full effect to the Warrants indirectly owned by the reporting person, each subject to a 9.99% Blocker.


SCHEDULE 13G


 
Ionic Ventures, LLC
 
Signature:/s/ Ionic Ventures, LLC
Name/Title:Keith Coulston, Manager of Ionic Management, LLC, Manager of Ionic Ventures, LLC
Date:02/04/2025
 
Ionic Management, LLC
 
Signature:/s/ Ionic Management, LLC
Name/Title:Keith Coulston, Manager
Date:02/04/2025
 
Brendan O'Neil
 
Signature:/s/ Brendan O'Neil
Name/Title:Brendan O'Neil
Date:02/04/2025
 
Keith Coulston
 
Signature:/s/ Keith Coulston
Name/Title:Keith Coulston
Date:02/04/2025
primary_doc.xml